SpectronRx
Amair Mohammed is an accomplished chemist with a solid background in research and development, currently serving as a Research and Development Chemist at SpectronRx since April 2022. Prior to this role, Amair held the position of Analytical Development Chemist III at Cambrex from July 2020 to April 2022, and worked as a Research Chemist at MPP Group, LLC from 2017 to July 2020. Amair's educational qualifications include a Master of Science in Pharmaceutics with a focus on Industrial Pharmacy from Long Island University, earned between 2015 and 2017, as well as a Bachelor of Science in Pharmacy from Osmania University, obtained from 2010 to 2014.
SpectronRx
1 followers
SpectronRx is a CDMO that is FDA and EMA inspected. We are licensed to handle multiple Therapeutic and Diagnostic isotopes pharmaceutical grade including Pb-212, Lu-177, Ac-225 and I-131 for various clinical applications. Spectron operates under a quality program that has been inspected by the FDA with approved drugs FDG, NaF and Ammonia. Spectron provides labeling and contract manufacturing services as it relates to Lu-177, Ac-225, I-131, I-124, I-111, Zr-89, Copper-64 and Fluorine-18.